SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Sundström Elisabeth) srt2:(2010-2014)"

Sökning: WFRF:(Sundström Elisabeth) > (2010-2014)

  • Resultat 1-10 av 36
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Andersson, Leif, et al. (författare)
  • ZBED6 : the birth of a new transcription factor in the common ancestor of placental mammals
  • 2010
  • Ingår i: Transcription. - : Informa UK Limited. - 2154-1272 .- 2154-1264. ; 1:3, s. 144-148
  • Tidskriftsartikel (refereegranskat)abstract
    • A DNA transposon integrated into -the genome of a primitive mammal some 200 million years ago and, millions of years later, it evolved an essential function in the common ancestor of all placental mammals. This protein, now named ZBED6, was recently discovered because a mutation disrupting one of its binding sites, in an intron of the IGF2 gene, makes pigs grow more muscle. These findings have revealed a new mechanism for regulating muscle growth as well as a novel transcription factor that appears to be of major importance for transcriptional regulation in placental mammals.
  •  
2.
  •  
3.
  • Baranowska Körberg, Izabella, et al. (författare)
  • A Simple Repeat Polymorphism in the MITF-M Promoter Is a Key Regulator of White Spotting in Dogs
  • 2014
  • Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 9:8, s. e104363-
  • Tidskriftsartikel (refereegranskat)abstract
    • The white spotting locus (S) in dogs is colocalized with the MITF (microphtalmia-associated transcription factor) gene. The phenotypic effects of the four S alleles range from solid colour (S) to extreme white spotting (s(w)). We have investigated four candidate mutations associated with the s(w) allele, a SINE insertion, a SNP at a conserved site and a simple repeat polymorphism all associated with the MITF-M promoter as well as a 12 base pair deletion in exon 1B. The variants associated with white spotting at all four loci were also found among wolves and we conclude that none of these could be a sole causal mutation, at least not for extreme white spotting. We propose that the three canine white spotting alleles are not caused by three independent mutations but represent haplotype effects due to different combinations of causal polymorphisms. The simple repeat polymorphism showed extensive diversity both in dogs and wolves, and allele-sharing was common between wolves and white spotted dogs but was non-existent between solid and spotted dogs as well as between wolves and solid dogs. This finding was unexpected as Solid is assumed to be the wild-type allele. The data indicate that the simple repeat polymorphism has been a target for selection during dog domestication and breed formation. We also evaluated the significance of the three MITF-M associated polymorphisms with a Luciferase assay, and found conclusive evidence that the simple repeat polymorphism affects promoter activity. Three alleles associated with white spotting gave consistently lower promoter activity compared with the allele associated with solid colour. We propose that the simple repeat polymorphism affects cooperativity between transcription factors binding on either flanking sides of the repeat. Thus, both genetic and functional evidence show that the simple repeat polymorphism is a key regulator of white spotting in dogs.
  •  
4.
  • Bergman, Åke, et al. (författare)
  • Insamling och kemisk analys av miljöföroreningar i svensk modersmjölk - Resultat från 2008-2010 : Rapport till Naturvårdsverket – 2010-11-24
  • 2010
  • Rapport (övrigt vetenskapligt/konstnärligt)abstract
    • Projekten, såsom det först formulerades, avsåg insamling av mjölkprover från mödrar boende i Stockholm, Göteborg, Lund respektive Umeå. Redan första året visade det sig svårt att få in prover från samtliga platser varför provinsamlingen 2008 -2010 koncentrerades till Göteborg och Stockholm. Prover från dessa städer har levererats till Naturhistoriska riksmuseet för dokumentering, preparering och lagring. Såväl individuella prover som poolade sådana har analyserats med avsikt att särskilt studera prover från Göteborg på individuell basis. Proverna för 2008 inkluderade 10 individuella prover och fyra homogenat och för prover från 2009/2010, 19 individuella prover samt två homogenat. De kemiska ämnen som analyserades tillhör följande klasser av miljöföroreningar: organiska klorpesticider, polyklorerade bifenyler (PCB) samt polybromerade difenyletrar (PBDE). Antalet enskilda analyter har i första hand avgjorts av ämnenas förekomst i proverna, men de som rapporteras är ett drygt 20-tal ämnen (se nedan).Den i särklass viktigaste miljöföroreningen bland de som här studeras är 4,4’-DDE. Den förekommer i halter mellan 20 och 130 ng/g fett, 2008-2010 i Göteborg medan halten i homogenat från 2007 låg på ca. 185 ng/g fett. I Stockholmsmödrarnas mjölk från 2008 låg halten på 70-80 ng/g fett men 2009/2010 var halten uppe i ca. 150 ng/g fett. De senare värdena ligger i paritet med observerade halter 2003, 2004 och 2007. Variationen är sådan att det inte ter sig finnas någon trend i haltutvecklingen mellan åren. Inte heller någon geografisk trend tycks förekomma, men fördjupade analyser av dessa data krävs för att säkerställa de statistiska observationerna. Övriga klororganiska bekämpningsmedel, inkl. hexaklorbensen (HCB) förekommer i halter som är <10% av 4,4’-DDE. De dominerande PCB-kongenerna är CB-138, -153 och -180 men dessa förekommer i halter som är lägre än 50% av det som 4,4’-DDE förekommer i. Flertalet PCB-kongener förekommer i sub-10 ng/g fett-halter i modersmjölken oavsett ursprungsstad (Göteborg eller Stockholm).ΣPCB-halten ligger i nivå med koncentrationen av 4,4’-DDE. Koncentrationerna av polybromerade difenyletrar (PBDE) är låga. De enskilda PBDE-kongenerna har mestadels halter på under 1 ng/g fett. BDE-209 förekommer mycket sällan i kvantifierbar halt i modersmjölken. Av lägre bromerade difenyletrar dominerar fortfarande BDE-47.Utanför kontraktet tillförs här också data för halter och trender av polyfluorerade kemikalier i modersmjölk från Stockholm 1972 till 2008. De ämnen som analyserats i modersmjölken är perfluorooktansulfonat (PFOS), perfluorohexansulfonat (PFHS) samt perfluorooktansyra (PFOA). Resultaten redovisar entydigt ämnenas uppåtgående trend fram till omkring 2000 varefter koncentrationerna faller.
  •  
5.
  • Curik, Ino, et al. (författare)
  • Complex Inheritance of Melanoma and Pigmentation of Coat and Skin in Grey Horses
  • 2013
  • Ingår i: PLOS Genetics. - : Public Library of Science (PLoS). - 1553-7390 .- 1553-7404. ; 9:2, s. e1003248-
  • Tidskriftsartikel (refereegranskat)abstract
    • The dominant phenotype of greying with age in horses, caused by a 4.6-kb duplication in intron 6 of STX17, is associated with a high incidence of melanoma and vitiligo-like skin depigmentation. However, the progressive greying and the incidence of melanoma, vitiligo-like depigmentation, and amount of speckling in these horses do not follow a simple inheritance pattern. To understand their inheritance, we analysed the melanoma grade, grey level, vitiligo grade, and speckling grade of 1,119 Grey horses (7,146 measurements) measured in six countries over a 9-year period. We estimated narrow sense heritability (h(2)), and we decomposed this parameter into polygenic heritability (h(POLY)(2)), heritability due to the Grey (STX17) mutation (h(STX17)(2)), and heritability due to agouti (ASIP) locus (h(ASIP)(2)). A high heritability was found for greying (h(2) = 0.79), vitiligo (h(2) = 0.63), and speckling (h(2) = 0.66), while a moderate heritability was estimated for melanoma (h(2) = 0.37). The additive component of ASIP was significantly different from zero only for melanoma (h(ASIP)(2) = 0.02). STX17 controlled large proportions of phenotypic variance (h(STX17)(2) = 0.18-0.55) and overall heritability (h(STX17)(2)/h(2) = 0.28-0.83) for all traits. Genetic correlations among traits were estimated as moderate to high, primarily due to the effects of the STX17 locus. Nevertheless, the correlation between progressive greying and vitiligo-like depigmentation remained large even after taking into account the effects of STX17. We presented a model where four traits with complex inheritance patterns are strongly influenced by a single mutation. This is in line with evidence of recent studies in domestic animals indicating that some complex traits are, in addition to the large number of genes with small additive effects, influenced by genes of moderate-to-large effect. Furthermore, we demonstrated that the STX17 mutation explains to a large extent the moderate to high genetic correlations among traits, providing an example of strong pleiotropic effects caused by a single gene.
  •  
6.
  • d'Amore, Francesco, et al. (författare)
  • Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma : NLG-T-01
  • 2012
  • Ingår i: Journal of Clinical Oncology. - 0732-183X .- 1527-7755. ; 30:25, s. 3093-3099
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose Systemic peripheral T-cell lymphomas (PTCLs) respond poorly to conventional therapy. To evaluate the efficacy of a dose-dense approach consolidated by up-front high-dose chemotherapy (HDT) and autologous stem-cell transplantation (ASCT) in PTCL, the Nordic Lymphoma Group (NLG) conducted a large prospective phase II study in untreated systemic PTCL. This is the final report, with a 5-year median follow-up, of the NLG-T-01 study. Patients and Methods Treatment-naive patients with PTCL age 18 to 67 years (median, 57 years) were included. Anaplastic lymphoma kinase (ALK) -positive anaplastic large-cell lymphoma (ALCL) was excluded. An induction regimen of six cycles of biweekly CHOEP (cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone) was administered (in patients age > 60 years, etoposide was omitted). If in complete or partial remission, patients proceeded to consolidation with HDT/ASCT. Results Of 166 enrolled patients, 160 had histopathologically confirmed PTCL. The majority presented with advanced-stage disease, B symptoms, and elevated serum lactate dehydrogenase. A total of 115 underwent HDT/ASCT, with 90 in complete remission at 3 months post-transplantation. Early failures occurred in 26%. Treatment-related mortality was 4%. At 60.5 months of median follow-up, 83 patients were alive. Consolidated 5-year overall and progression-free survival (PFS) were 51% (95% CI, 43% to 59%) and 44% (95% CI, 36% to 52%), respectively. Best results were obtained in ALK-negative ALCL. Conclusion Dose-dense induction followed by HDT/ASCT was well tolerated and led to long-term PFS in 44% of treatment-naive patients with PTCL. This represents an encouraging outcome, particularly considering the high median age and adverse risk profile of the study population. Therefore, dose-dense induction and HDT/ASCT are a rational up-front strategy in transplantation-eligible patients with PTCL. J Clin Oncol 30: 3093-3099. (C) 2012 by American Society of Clinical Oncology
  •  
7.
  • Geisler, Christian H., et al. (författare)
  • Nordic MCL2 trial update : six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur
  • 2012
  • Ingår i: British Journal of Haematology. - : Wiley. - 0007-1048 .- 1365-2141. ; 158:3, s. 355-362
  • Tidskriftsartikel (refereegranskat)abstract
    • Mantle cell lymphoma (MCL) is a heterogenic non-Hodgkin lymphoma entity, with a median survival of about 5 years. In 2008 we reported the early based on the median observation time of 4 years results of the Nordic Lymphoma Group MCL2 study of frontline intensive induction immunochemotherapy and autologous stem cell transplantation (ASCT), with more than 60% event-free survival at 5 years, and no subsequent relapses reported. Here we present an update after a median observation time of 6.5 years. The overall results are still excellent, with median overall survival and response duration longer than 10 years, and a median event-free survival of 7.4 years. However, six patients have now progressed later than 5 years after end of treatment. The international MCL Prognostic Index (MIPI) and Ki-67-expression were the only independent prognostic factors. Subdivided by the MIPI-Biological Index (MIPI + Ki-67, MIPI-B), more than 70% of patients with low-intermediate MIPI-B were alive at 10 years, but only 23% of the patients with high MIPI-B. These results, although highly encouraging regarding the majority of the patients, underline the need of a risk-adapted treatment strategy for MCL.
  •  
8.
  • Geisler, Christian H., et al. (författare)
  • The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
  • 2010
  • Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 115:8, s. 1530-1533
  • Tidskriftsartikel (refereegranskat)abstract
    • Mantle cell lymphoma (MCL) has a heterogeneous clinical course. The recently proposed Mantle Cell Lymphoma International Prognostic Index (MIPI) predicted the survival of MCL better than the International Prognostic Index in MCL patients treated with conventional chemotherapy, but its validity in MCL treated with more intensive immunochemotherapy has been questioned. Applied here to 158 patients of the Nordic MCL2 trial of first-line intensive immunochemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation, the MIPI and the simplified MIPI (s-MIPI) predicted survival significantly better (P < .001) than the International Prognostic Index (P > .004). Both the MIPI and the s-MIPI mainly identified 2 risk groups, low and intermediate versus high risk, with the more easily applied s-MIPI being just as powerful as the MIPI. The MIPI(B) (biological), incorporating Ki-67 expression, identified almost half of the patients as high risk. We suggest that also a simplified MIPI(B) is feasible.
  •  
9.
  • Hellström, Anders R., et al. (författare)
  • Sex-linked barring in chickens is controlled by the CDKN2A/B tumour suppressor locus
  • 2010
  • Ingår i: Pigment Cell and Melanoma Research. - : Blackwell Publishing Group. - 1755-1471 .- 1755-148X. ; 23:4, s. 521-530
  • Tidskriftsartikel (refereegranskat)abstract
    • Sex-linked barring, a common plumage colour found in chickens, is characterized by black and white barred feathers. Previous studies have indicated that the white bands are caused by an absence of melanocytes in the feather follicle during the growth of this region. Here we show that Sex-linked barring is controlled by the CDKN2A/B locus, which encodes the INK4b and ARF transcripts. We identified two non-coding mutations in CDKN2A that showed near complete association with the phenotype. Also identified were two missense mutations at highly conserved sites, V9D and R10C, and every bird tested with a confirmed Sex-linked barring phenotype carried one of these missense mutations. Further work is required to determine if one of these or a combined effect of two or more CDKN2A mutations is causing Sex-linked barring. This novel finding provides the first evidence that the tumour suppressor locus CDKN2A/B can affect pigmentation phenotypes and sheds new light on the functional significance of this gene.
  •  
10.
  • Helmersson-Karlqvist, Johanna, et al. (författare)
  • Cytokine mediated inflammation is involved in the early stages of kidney damage and dysfunction
  • 2011
  • Ingår i: XIII Svenska Kardiovaskulära vårmötet. - Örebro.
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
    • Background: Patients with severe chronic kidney disease (CKD) are characterized by increased inflammatory activity and higher oxidative stress, conditions that have been suggested to mediate the substantially increased risk for cardiovascular disease (CVD) in these patients. However, also individuals with mild signs of kidney damage and dysfunction have been shown to have an increased risk for CVD. Yet, data on the association between mild signs of kidney damage and dysfunction and markers of inflammation and oxidative stress in the community is scarce. Research Design and Methods: Accordingly, we investigated the cross-sectional associations between cystatin C based glomerular filtration rate (GFR), urinary albumin creatinine ratio (ACR), and markers of cytokine mediated inflammation (interleukin 6 [IL-6], high sensitivity C reactive protein [hsCRP], serum amyloid A [SAA]), cyclooxygenas-mediated inflammation (urinary prostaglandin F2-alpha [PGF2alpha]) and oxidative stress (urinary F2-isprostanes) in a sub-sample of a community based cohort (Uppsala Longitudinal Study of Adult Men, ULSAM, n=648, mean age 77 year) with normal eGFR (>60 ml/min/1.73m2 ) and normal ACR (<30 µmol/L) Results: In multivariable linear regression models adjusting for age, BMI, smoking, systolic and diastolic blood pressure, total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides and treatment with statin, ACE-inhibit-, ASA-, anti inflammation- , cortisone medication, eGFR was inversely associated with lower hsCRP (p<0.008), lower IL-6 (p<0.01), and ACR was positive associated with higher hsCRP (p=0.01), higher IL-6 (p=<0.004) and higher SAA (p=0.001). No significant association was seen between PGF2alpha, F2-isoprostanes and eGFR and ACR. Conclusion: Our community based data suggest that cytokine mediated inflammation is involved in the early stages of kidney damage and dysfunction, while cyclooxygenas-mediated inflammation and oxidative stress is not. Further studies are needed in order to evaluate to what extent cytokine mediated inflammation mediates the increased CVD risk seen in individuals with mild signs of kidney damage and dysfunction.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 36
Typ av publikation
tidskriftsartikel (26)
konferensbidrag (5)
bok (3)
rapport (1)
doktorsavhandling (1)
Typ av innehåll
refereegranskat (26)
övrigt vetenskapligt/konstnärligt (9)
populärvet., debatt m.m. (1)
Författare/redaktör
Larsson, Anders (13)
Risérus, Ulf (13)
Ingelsson, Erik (13)
Sundström, Johan (13)
Ärnlöv, Johan (12)
Basu, Samar (11)
visa fler...
Sundström, Elisabeth (11)
Andersson, Leif (9)
Sundström, Christer (7)
Lind, Lars (6)
Ralfkiaer, Elisabeth (6)
Delabie, Jan (6)
Jerkeman, Mats (5)
Laurell, Anna (5)
Ehinger, Mats (5)
Nilsson-Ehle, Herman (4)
Geisler, Christian H (4)
Kolstad, Arne (4)
Karjalainen-Lindsber ... (4)
Elonen, Erkki (4)
Jiang, Lin (4)
Jonas, Elisabeth (3)
Andersson, Göran (3)
Lindblad-Toh, Kersti ... (3)
Rydhmer, Lotta (3)
Röcklinsberg, Helena (3)
Sundström, Jens (3)
Räty, Riikka (3)
Sandin, Per (3)
Zhu, Li-Hua (3)
Lauritzsen, Grete F. (3)
Nicolia, Alessandro (3)
Brown, Peter (3)
Fagerli, Unn-Merete (3)
Bentzen, Hans (3)
Eriksson, Mikael (2)
Pedersen, Lone Bredo (2)
Raty, Riikka (2)
Gronbaek, Kirsten (2)
Grønbæk, Kirsten (2)
Nordstrom, Marie (2)
Rubin, Carl-Johan (2)
Loft, Annika (2)
Bogsrud, Trond Velde (2)
Hansen, Per Boye (2)
Lauritzsen, Grete Fo ... (2)
Lehmann, Anne Kristi ... (2)
Schildt, Jukka (2)
Kostova-Aherdan, Kam ... (2)
Frederiksen, Henrik (2)
visa färre...
Lärosäte
Uppsala universitet (25)
Sveriges Lantbruksuniversitet (13)
Karolinska Institutet (11)
Högskolan Dalarna (11)
Lunds universitet (8)
Umeå universitet (2)
visa fler...
Linköpings universitet (2)
Göteborgs universitet (1)
Naturvårdsverket (1)
visa färre...
Språk
Engelska (33)
Svenska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (16)
Lantbruksvetenskap (11)
Naturvetenskap (6)
Teknik (1)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy